Antibiotic)resistance)is)one)of)the)foremost)threats)to)human)health 1,2 ,)yet) 13 the)spread)of)resistance)is)poorly)understood.)Resistant)and)sensitive) 14 strains)of)the)same)bacteria)nearly)always)coexist)in)host)populations 3-5 ,) 15 but)mathematical)models)of)disease)transmission)have)failed)to)identify)a) 16 general,)empirically&supported)mechanism)that)can)reproduce)this) 17 phenomenon 6-9 .)Such)a)model)should)be)structurally)neutral 10 ,)meaning) 18 that)coexistence)arises)from)the)biology)of)sensitive)and)resistant)strains) 19 rather)than)being)an)assumption)embedded)into)the)model)structure.) 20 However,)existing)models)have)only)applied)the)principle)of)structural) 21 neutrality)at)the)population)level,)not)within)individual)hosts)where) 22 resistant)and)sensitive)strains)may)interact.)Here,)we)show)that)within&host) 23 dynamics)between)resistant)and)sensitive)strains)creates)frequency& 24 dependent)selection)for)resistance,)promoting)coexistence)at)the) 25 population)level,)and)that)extending)structural)neutrality)to)the)within& 26 host)level)allows)us)to)reproduce)empirical)patterns)of)resistance)in) 27 commensal)bacteria)across)30)European)countries.)In)doing)so,)we)identify) 28 a)parsimonious)and)biologically&plausible)explanation)for)coexistence)that) 29 resolves)a)long&standing)conflict)between)theoretical)prediction)and) 30 empirical)observation.)Simple)mathematical)models)that)mechanistically) 31 capture)resistance)transmission)dynamics)will)allow)us)to)more)accurately) 32 predict)the)impact)of)much&needed)strategies)for)managing)resistance.)) 33 (Fig.)1b) .#This#competitive#exclusion#is#not#observed#empirically,#and#there#is# 54 little#evidence#that#the#intermediate#resistance#prevalences#we#observe#are#only# 55 transient#states#on#the#way#to#competitive#exclusion 7 .#Instead,#sensitive#and# 56 resistant#strains#of#the#same#bacteria#stably#coexist#in#natural#populations 7-9 ,# 57 with#the#prevalence#of#resistance#to#a#particular#antibiotic#gradually#increasing# 58 with#consumption#of#that#antibiotic 3-5 # (Fig.)1c) (Fig.)2d) 
.#Consistent#with#the#results#for#S.! 168 pneumoniae#penicillin#nonPsusceptibility# (Fig.)2) 
Methods) 236 ) 237
SingleGcarriage!model#-#The#singlePcarriage#model#is#given#by# 238
Here,#S!=!S(t)#is#the#fraction#of#sensitive#strain#carriers#in#the#population;#R!=#R(t)# 244 is#the#fraction#of#resistant#strain#carriers#in#the#population;#and#X#=#X(t)#is#the# 245 fraction#of#nonPcarriers.#The#parameter#β#is#the#personPtoPperson#transmission# 246 rate#of#the#sensitive#strain,#u#is#the#natural#clearance#rate,#τ#is#the#per#capita#rate# 247 of#antibiotic#treatment,#and#c#is#the#transmission#cost#of#resistance.# 248
# 249
WithinGhost!balancing!model#-#Following#previous#work 7,#10 ,#the#balancing# 250 model#is#given#by# 251
WithinGhost!neutrality!model#-#The#novel#neutral#model#is#given#by# 264
Here,#the#compartment#SR#=#SR(t)#captures#the#fraction#of#the#population# 272 predominantly#colonised#with#sensitive#bacteria,#but#also#carrying#a#small# 273 amount#of#resistant#bacteria,#and#S#+#SR#gives#the#effective#population#burden#of# 274 sensitivePstrain#colonisation.#The#RS#=#Rs(t)#compartment#shown#in#Fig.)2e#is# 275
WithinGhost!neutrality!model!with!succession#-#Finally,#the#neutral#model#with# 279 succession#is#given#by# 280 
lower#and#upper#bounds#of#duration#of#carriage,#respectively,#and#0#otherwise;# 325 
Priors#for#all#model#fitting#were#identified#from#the#literature#and#were#bacteriaP 344 specific#(Supplementary)Information).# 345 prevalence# (Fig.)3a&c) Neutral plus succession, no S R → S clearance Neutral plus succession, with S R → S clearance Antibiotic treatment rate (defined daily doses per 1000 people), primary care
Resistance prevalence
